Wellington Management Group
LBPH

Wellington Management Group’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Wellington Management Group’s Portfolio LBPH Stock Details LBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,590,072
Closed -$53M – 2066
2024
Q3 		$53M Sell
1,590,072
-188,899
-11% -$6.5M 0.01% 683
2024
Q2 		$48.1M Sell
1,778,971
-357,392
-17% -$7.05M 0.01% 708
2024
Q1 		$46.1M Buy
+2,136,363
New +$46.6M 0.01% 730
2021
Q2 		– Sell
-11,333
Closed -$185K – 2385
2021
Q1 		$185K Buy
+11,333
New +$185K ﹤0.01% 2061

Wellington Management Group's LBPH Position: Q4 2024 in Review

Wellington Management Group sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 1,590,072 shares — an estimated $53M sold.

Wellington Management Group first reported a position in LBPH in Q1 2021 and held it in 4 quarters. The position peaked at $53M in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

  • Wellington Management Group reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Wellington Management Group sold 1,590,072 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $53M.
  • Wellington Management Group first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 4 quarters.
  • Wellington Management Group's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $53M in Q3 2024.
  • 0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Wellington Management Group's 13F filing for Q4 2024, filed 12 Feb 2025.